The convergence of functional biology, AI, and translational medicine is beginning to reshape how immune systems are studied, ...
Agricultural genomics is beginning to move beyond the limits of a single “reference” crop genome. In a proof-of-concept study, researchers used pangenome-guided breeding to recover useful DNA ...
Memories can survive even after the brain temporarily loses more than half of its synaptic connections, according to the results of a study in mice that challenge the long-held view that long-term ...
Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study, the Parkinson’s Precision ...
Self-optimization is the next evolutionary step for bioprocessing purification systems and, although that step is near, it ...
Emerging technologies like laboratory automation and generative AI are promising to revolutionize bioindustry workflows.
A scalable platform to discover molecular glue degraders has been developed, identifying the first metabolically activated ...
COVID-19 can reactivate dormant viruses, including Epstein-Barr and cytomegalovirus, according to a large NIH-funded study.
Zebrafish were bred to lack a working copy of a gene that could be studied to better understand how genetic faults could lead ...
Vivodyne says that eight of the world’s largest pharma companies have paid for early access to the human biological datacenter platform.
The puppies represent a key first step towards addressing canine allergenicity and mark potentially a significant advance in ...
StockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel
Capricor Therapeutics is hoping for a better outcome for its resubmitted BLA for its lead pipeline candidate Deramiocel.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results